![Seth Ettenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seth Ettenberg
Chief Executive Officer at BlueRock Therapeutics Canada ULC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Emile Nuwaysir | M | 55 |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | 7 years |
John Green | M | 43 | 6 years | |
Arlene Morris | F | 72 | 5 years | |
Matthew Ros | M | 57 | 5 years | |
Karen Ferrante | M | 66 | 6 years | |
Jessica Sachs | M | 49 | 7 years | |
Michael J. Scott | M | 60 |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | 7 years |
Jerel Davis | M | 47 |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | - |
Sara Saltzman | F | - | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christiana Stamoulis | F | 53 | 4 years | |
Bruce Booth | M | 49 | 6 years | |
Robert Perez | M | 59 | 1 years | |
Jörn Aldag | M | 65 | 4 years | |
Matthew Osborne | M | - | 1 years | |
Liam Ratcliffe | M | 60 | 4 years | |
Shane Kovacs | M | 50 |
BlueRock Therapeutics LP
![]() BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | 2 years |
Geoffrey Hodge | M | 59 | - | |
Michael Vasconcelles | M | 61 | 4 years | |
Jürgen Eckhardt | M | 57 |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | 5 years |
Jeff Michaels | M | - | - | |
Bradley Hartman | M | - | 2 years | |
Mert Aktar | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 18 | 81.82% |
Canada | 4 | 18.18% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Seth Ettenberg
- Personal Network